Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2023-12-28

FDA Approved: MELOXICAM — Supplemental Application (AiPing Pharmaceutical, Inc)

View source ↗

Summary

FDA approved AiPing Pharmaceutical, Inc.'s supplemental application for MELOXICAM (meloxicam).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • MELOXICAM (MELOXICAM)

Snippet

SUPPL AP for MELOXICAM (MELOXICAM)